Alignment of Practice Guidelines with Targeted-therapy Drug Funding Policies in Ontario

Abstract

ConclusionsFor use of tts, most recommendations in pebc cpgs are based on meta-analyses or phase iii data, and funding decisions were strongly associated with those recommendations. Our data suggest a trend toward increased rates of funding for therapies with statistically significant improvements in os.

Costs and concerns in cancer care

“…The Canadian province of Ontario developed the publicly funded Ontario Public Drug Programs in 1995. 14,15 However, a growing number of high profile cases of media and political pressure have also influenced drug approvals in the province. 10 Some recently developed anticancer drugs appear to be a major advance.…”

Impact of the Pan-Canadian Oncology Drug Review on Provincial Concordance with Respect to Cancer Drug Funding Decisions and Time to Funding

“…An evidence-based drug review process is a critical step in ensuring access to effective and cost-effective drugs. The recommendations of regional evidence-based cancer care programs affect funding decisions by government organizations 3 . Integrating cost effectiveness analyses into the review process further ensures that taxpayers acquire access to drugs that are cost-effective 4 .…”